11月17日,Cytomx Therapeutics, Inc.(CTMX.US)公布财报,公告显示公司2024财年第三财季净利润为5.74百万美元,同比增加91.97%;其中营业收入为33.43百万美元,同比增加26.72%,每股基本收益为0.07美元。从资产负债表来看,Cytomx Therapeutics, Inc.(CTMX.US)总负债1.62亿美元,其中短期债务5.00百万美元,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.